Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Apoyo para cuidadores culturalmente sensibles

21 de octubre de 2026 actualizado por: Sheria Robinson-Lane, University of Michigan

Programa de apoyo culturalmente receptivo para cuidadores afroamericanos de personas con demencia

Black family caregivers of older adults with Alzheimer's disease and/or related dementias (ADRD), have an increased mortality risk related to pre-existing health conditions and stress. Targeted, culturally responsive, health interventions that help Black ADRD caregivers to effectively manage their own health and use community preferenced ways of coping, can improve caregivers' overall health, perceived ability to provide care for a person with ADRD (self-efficacy), and increases the likelihood that they will experience benefits from caregiving. This clinical trial pilot will test the feasibility of a community based intervention designed to improve health outcomes for Black family caregivers of persons with ADRD.

Descripción general del estudio

Estado

Terminado

Intervención / Tratamiento

Descripción detallada

The proposed intervention is a peer-supportive and facilitator-led video teleconference program that will engage small groups of caregivers weekly over 6 weeks. Each week participants (n = 36, 2-5/group) will receive a different culturally relevant caregiving or personal health strategy to practice. During the support calls, a facilitator will provide an overview of the content covered and each participant will have the opportunity to discuss their past week and how they engaged the weekly strategy, or challenges that came up for them during the week. The format will be structured to ensure that core content is reviewed, and everyone can be equally engaged while flexible enough that caregivers can receive support in the areas they need. A battery of assessment measures will be taken at weeks 1 and 8.

Tipo de estudio

Intervencionista

Inscripción (Actual)

25

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Michigan
      • Ann Arbor, Michigan, Estados Unidos, 48109
        • University of Michigan

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion criteria for participation are as follows:

Self-identified as Black/ African American At least 18 years old Able to speak, understand, and hear spoken English Related to, or has a close personal relationship to a person over the age of 55 that has an ADRD diagnosis or evidence of cognitive impairment Regular access to a smartphone, tablet or computer with internet access that will allow video conferencing engagement.

Provides monitoring, and assistance in activities of daily living and or other care tasks for the care recipient.

-

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Caregiver Support

All participants in all groups will receive 6 weeks of caregiving support including a weekly video/teleconference call, and handouts covering relevant educational topics)

Caregivers engage in a weekly video/teleconference support group with a skilled facilitator to discuss various strategies for managing caregiving stress, challenging behaviors, and personal self-care.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Caregiver Self-efficacy for Obtaining Respite Care
Periodo de tiempo: 6 weeks

Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline.

6 weeks
Caregiver Self-Efficacy for Controlling Upsetting Thoughts
Periodo de tiempo: 6 Weeks

Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline.

6 Weeks
Caregiver Self-Efficacy for Responding to Disruptive Behaviors
Periodo de tiempo: 6 Weeks

Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline.

6 Weeks

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Positive Aspects of Caregiving
Periodo de tiempo: 6 weeks

The Positive Aspects of Caregiving tool is a brief assessment measure that asks questions about caregiving experiences that made the caregiver feel good about providing care. Responses are rated from 1, disagree a lot, to 5, agree a lot. Scores range from 9 to 45 with higher scores indicating more positive experiences related to family caregiving.

6 weeks

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

6 de marzo de 2025

Finalización primaria (Actual)

22 de octubre de 2025

Finalización del estudio (Actual)

22 de octubre de 2025

Fechas de registro del estudio

Enviado por primera vez

19 de abril de 2021

Primero enviado que cumplió con los criterios de control de calidad

19 de abril de 2021

Publicado por primera vez (Actual)

23 de abril de 2021

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

13 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

21 de octubre de 2026

Última verificación

1 de octubre de 2026

Más información

Términos relacionados con este estudio

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • HUM00230940
  • 1K01AG065420-01A1 (Subvención/contrato del NIH de EE. UU.)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

It is anticipated that the following data will be generated and made available 1) published tables, figures, graphs, and tables of data used for making graphs; 2) published journal papers, conference papers, annual reports and the final report; and 3) educational materials resulting from intervention development. All data will conform with relevant data and terminology standards.

Marco de tiempo para compartir IPD

No less than 5 years following the date of the project completion or the date of study publication.

Criterios de acceso compartido de IPD

To facilitate data sharing, project data will be made publicly available via a university-managed repository Deep Blue.

Tipo de información de apoyo para compartir IPD

  • PROTOCOLO DE ESTUDIO
  • SAVIA
  • CÓDIGO_ANALÍTICO
  • RSC

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir